• The blockbuster diabetes drug Ozempic could be manufactured for less than $5 a month, even as Novo Nordisk charges almost $1,000 per month for the injection in the U.S. before insurance, a new study suggests.
  • Researchers found that a month’s supply of the treatment could be made for an estimated 89 cents to $4.73, figures that include a profit margin.
  • The study raises more questions about the hefty price tag of the top-selling diabetes treatment along with similar drugs for weight loss, which are all part of a new class of drugs called GLP-1s.